Endocrine‐related adverse events associated with immune‐checkpoint inhibitors in patients with melanoma

BACKGROUND: Immune‐checkpoint inhibitors have been shown to improve survival in melanoma patients, but can also trigger immune‐related endocrinopathies, especially hypophysitis and thyroid dysfunction. METHODS: To assess the incidence and the spectrum of endocrinopathies in melanoma patients treated...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Med
Main Authors: Kassi, Eva, Angelousi, Anna, Asonitis, Nikolaos, Diamantopoulos, Panagiotis, Anastasopoulou, Amalia, Papaxoinis, George, Kokkinos, Michalis, Giovanopoulos, Ilias, Kyriakakis, Georgios, Petychaki, Fotini, Savelli, Akrivi, Benopoulou, Olga, Gogas, Helen
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2019
Assuntos:
Clinical Cancer Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6825974/
https://ncbi.nlm.nih.gov/pubmed/31518074
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.2533
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados